Amidst rising concerns, the Health Committee questions the Department of Health’s decision to award R15.5 billion in ARV contracts to foreign firms, highlighting the potential sidelining of capable local manufacturers.
Health Committee criticises R15bn ARV tender: Are local manufacturers being sidelined?
Amidst rising concerns, the Health Committee questions the Department of Health’s decision to award R15.5 billion in ARV contracts to foreign firms, highlighting the potential sidelining of capable local manufacturers.
Firms in IDT scandal resurface in R379m oxygen plant tender
Another oxygen plant tender has been marred by scandal and irregularities.
Firms in IDT scandal resurface in R379m oxygen plant tender
Another oxygen plant tender has been marred by scandal and irregularities.
WATCH | REPORTING NOTES: Inside the new multimillion-rand oxygen-for-hospitals tender | News24
The Development Bank of South Africa has awarded a new R379-million contract to supply PSA oxygen plants to hospitals across South Africa.
Health department caught in a lie? MPs tear ARVs tender worth R15.5 bn apart | The Citizen
Data shows most ARVs are imported into South Africa.
EXCLUSIVE | Cipla challenges Aids drug tender in court
Pharmaceutical manufacturer Cipla takes legal action against Aids drug tender
Concerns raised over R15 billion ARV tender as EFF calls for SIU investigation
The EFF is demanding an investigation into the R15 billion ARV tender, highlighting serious concerns over irregularities, potential price collusion, and the exclusion of local suppliers.
Same players, different game: Firms from R836m PSA oxygen scandal resurface in new tender | News24
Companies previously disqualified from a scandal-plagued R836-million Independent Development Trust oxygen tender have won the contract for a new R379-million Development Bank of South Africa tender in a process meant to address previous irregularities.
South Africa spends R15.5bn on ARVs, but can’t verify if any are locally made | The Citizen
The government classifies several major pharmaceutical suppliers as local manufacturers, but Indian customs data suggests otherwise.